[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis].
D018491:Dopamine Agonists / Q000627:therapeutic use*; D004878:Ergotamine / Q000009:adverse effects*; D005355:Fibrosis; D006331:Heart Diseases / Q000139:chemically induced / Q000473:pathology*; D006349:Heart Valve Diseases / Q000188:drug therapy*; D006801:Humans; D010479:Pergolide / Q000009:adverse effects* / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D018491:Dopamine Agonists; D014662:Vasoconstrictor Agents; D010479:Pergolide; D004878:Ergotamine
Valvulopathies sous pergolide: la saga des fibroses dues aux dérivés de l'ergot de seigle continue!